scPharmaceuticals Inc. (SCPH) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
scPharmaceuticals Inc. (SCPH) Bundle
Designed for accuracy, our scPharmaceuticals Inc. (SCPH) DCF Calculator enables you to evaluate scPharmaceuticals' valuation using real-world financial data and provides complete flexibility to modify all essential parameters for more accurate projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | 13.6 | 13.6 | 13.6 | 13.6 | 13.6 | 13.6 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -30.9 | -29.2 | -25.0 | -33.1 | -46.1 | 8.2 | 8.2 | 8.2 | 8.2 | 8.2 |
EBITDA, % | 100 | 100 | 100 | 100 | -338.86 | 60 | 60 | 60 | 60 | 60 |
Depreciation | .4 | .4 | .4 | .5 | .6 | 11.0 | 11.0 | 11.0 | 11.0 | 11.0 |
Depreciation, % | 100 | 100 | 100 | 100 | 4.61 | 80.92 | 80.92 | 80.92 | 80.92 | 80.92 |
EBIT | -31.2 | -29.6 | -25.5 | -33.5 | -46.7 | 8.2 | 8.2 | 8.2 | 8.2 | 8.2 |
EBIT, % | 100 | 100 | 100 | 100 | -343.46 | 60 | 60 | 60 | 60 | 60 |
Total Cash | 72.8 | 105.3 | 75.5 | 118.4 | 76.0 | 13.6 | 13.6 | 13.6 | 13.6 | 13.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .3 | .0 | .0 | .0 | 4.5 | 11.8 | 11.8 | 11.8 | 11.8 | 11.8 |
Account Receivables, % | 100 | 100 | 100 | 100 | 33.02 | 86.6 | 86.6 | 86.6 | 86.6 | 86.6 |
Inventories | 2.4 | .0 | .0 | 1.2 | 8.8 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 |
Inventories, % | 100 | 100 | 100 | 100 | 65.03 | 93.01 | 93.01 | 93.01 | 93.01 | 93.01 |
Accounts Payable | 1.1 | 1.7 | .5 | 1.5 | 4.0 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 29.43 | 85.89 | 85.89 | 85.89 | 85.89 | 85.89 |
Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | -0.29427 | -0.05885382 | -0.05885382 | -0.05885382 | -0.05885382 | -0.05885382 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -32.6 | -31.6 | -27.7 | -34.2 | -46.7 | 8.2 | 8.2 | 8.2 | 8.2 | 8.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -33.8 | -28.0 | -28.4 | -34.0 | -55.7 | 15.7 | 19.1 | 19.1 | 19.1 | 19.1 |
WACC, % | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 | 8.85 |
PV UFCF | ||||||||||
SUM PV UFCF | 71.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 20 | |||||||||
Terminal Value | 285 | |||||||||
Present Terminal Value | 186 | |||||||||
Enterprise Value | 258 | |||||||||
Net Debt | -7 | |||||||||
Equity Value | 265 | |||||||||
Diluted Shares Outstanding, MM | 39 | |||||||||
Equity Value Per Share | 6.87 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real SCPH financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on scPharmaceuticals' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life SCPH Financials: Pre-filled historical and projected data for scPharmaceuticals Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate scPharmaceuticals’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize scPharmaceuticals’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered scPharmaceuticals Inc. (SCPH) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for scPharmaceuticals Inc. (SCPH)'s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for scPharmaceuticals Inc. (SCPH)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for scPharmaceuticals Inc. (SCPH).
- Flexible Variables: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically determines scPharmaceuticals Inc. (SCPH)'s intrinsic value and Net Present Value.
- Ready-to-Use Data: Comes with historical and projected data for reliable analysis.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors focused on scPharmaceuticals Inc. (SCPH).
Who Should Use This Product?
- Investors: Accurately estimate scPharmaceuticals Inc.'s (SCPH) fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to scPharmaceuticals Inc. (SCPH).
- Consultants: Quickly customize the template for valuation reports tailored to scPharmaceuticals Inc. (SCPH) clients.
- Entrepreneurs: Gain insights into financial modeling practices employed by leading pharmaceutical companies.
- Educators: Use it as a teaching resource to illustrate valuation methodologies relevant to scPharmaceuticals Inc. (SCPH).
What the Template Contains
- Preloaded SCPH Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.